on 27 Sept 2012
Last Applicant/ Owned by
apceth GmbH und Co. KG
Max-Lebsche-Platz 30
München, , 81377
Serial Number
UK00911219276 filed on 27th Sept 2012
Registration Number
UK00911219276 registered on
4th Mar 2013
Correspondent Information
HERTIN UND PARTNER RECHTS- UND PATENTANWÄLTE PARTG MBB
Kurfürstendamm 54/55
Berlin,
10707
Stem cells; Hematopoietic and immune system cells; Genetically or otherwise modified cells; Cells which are propagated, cultivated and expanded in bioreactors; Cells for the purpose of tissue regeneration; Cells of animal origin.
Processing, preserving, freezing or thawing blood components, including stem cells obtained from umbilical cord blood, bone marrow, placenta and other parts of the human body, hematopoietic and immune system cells, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration, cells of animal origin; Patient-specific production of stem cells, hematopoietic and immune system cells, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration, cells of animal origin; Services relating to the processing of stem cells, hematopoietic and immune system cells, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration, cells of animal origin; Services related to the treatment and conservation of blood products, embryonic cells and placental cells; Stem cell laboratories, namely analysing stem cells, hematopoietic and immune system cells, genetically or otherwise modified cells, cells which are propagated, cultivated and expanded in bioreactors, cells for the purpose of tissue regeneration, cells of animal origin; Scientific and technological services in the field of removal, treatment and processing of human blood and umbilical cord blood, and removal, treatment and processing of living human cell material, in particular autologous stem cells; Scientific laboratories for isolating the aforesaid cell material, in particular stem cells; Scientific and technological services and research and design, in particular in the field of biotechnologies, of diagnosis and treatment of illnesses by means of stem cells.
Medical services, Namely stem cell therapies; services of a stem cell bank; Medical services, Namely removal and administration of stem cells; Medical consultancy in relation to stem cell therapy.
UK00911219276
Word
Individual